Business

Cenra Healthcare and Dr. Reddy's Strengthen Strategic Partnership to Expand Access to Medicines in Taiwan

Cenra Healthcare, the sales and marketing arm of Cenra Inc. (TWSE: 3716), today announced the deepening of its long-standing collaboration with the global pharmaceutical company Dr. Reddy's Laboratories (Taiwan) Ltd (Dr. Reddy's). Since the partnership began in 2020, the two companies have worked closely to introduce a diverse range of high-quality generic drugs and innovative formulations to patients in Taiwan, with a shared commitment to broadening access to affordable and clinically valuable

articleDr. Reddy's Laboratories Ltd.July 21, 20253/company/dr-reddys-laboratories-limited/news/cenra-healthcare-and-dr-reddys-strengthen-strategic-partnership-to-expand-access-to-medicines-in-taiwan
Cenra Healthcare and Dr. Reddy's Strengthen Strategic Partnership to Expand Access to Medicines in Taiwan

About this update from Dr. Reddy's Laboratories Ltd.

[{"type":"text","content":"TAIPEI, July 21, 2025 /PRNewswire/ -- Cenra Healthcare, the sales and marketing arm of Cenra Inc. (TWSE: 3716), today announced the deepening of its long-standing collaboration with the global pharmaceutical company Dr. Reddy's Laboratories (Taiwan) Ltd (Dr. Reddy's). Since the partnership began in 2020, the two companies have worked closely to introduce a diverse range of high-quality generic drugs and innovative formulations to patients in Taiwan, with a shared commitment to broadening access to affordable and clinically valuable treatments.","length":557,"tagName":"p"},{"type":"image","alt":"Left – Cenra Healthcare General Manager Lucas Lin; Right – Dr. Reddy’s Group Country Head Satheeshkumar Sriharan. (PRNewsfoto/Cenra Inc.)","displaySize":"","headline":null,"caption":"Left – Cenra Healthcare General Manager Lucas Lin; Right – Dr. Reddy’s Group Country Head Satheeshkumar Sriharan. (PRNewsfoto/Cenra Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/8567124a1b3d0ba32cbd5b597513d9b3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/R9uAkYWe0gvZXCQf4eKC7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/8567124a1b3d0ba32cbd5b597513d9b3","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2734918/DRL.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""We are proud to strengthen our collaboration with Dr. Reddy's, one of the world's leading pharmaceutical companies with strong R&D capabilities," said Lucas Lin, General Manager of Cenra Healthcare. "With Cenra Healthcare's broad market coverage and strong presence in Taiwan's healthcare landscape, we are well positioned to support our partners in promoting access to essential medicines. This partnership is built not just on product alignment, but on a shared belief in patient-centric care — delivering affordable, high-quality treatment options backed by long-term trust and mutual values."","length":637,"tagName":"p"},{"type":"text","content":"Over the past five years, Cenra Healthcare and Dr Reddy's have successfully introduced a number of key therapies in the field of oncology, including chemotherapy agents, hormone therapies, a...

More updates from Dr. Reddy's Laboratories Ltd.

Dr. ReddyCenra Inc.TaiwanDr. Reddy's Laboratories